Integrating HIV Prevention and Treatment: From Slogans to Impact

Salomon, Joshua A.; Hogan, Daniel R.; Stover, John; Stanecki, Karen A.; Walker, Neff; Ghys, Peter D.; Schwartländer, Bernhard
January 2005
PLoS Medicine;Jan2005, Vol. 2 Issue 1, p50
Academic Journal
Background Through major efforts to reduce costs and expand access to antiretroviral therapy worldwide, widespread delivery of effective treatment to people living with HIV/AIDS is now conceivable even in severely resource-constrained settings. However, the potential epidemiologic impact of treatment in the context of a broader strategy for HIV/AIDS control has not yet been examined. In this paper, we quantify the opportunities and potential risks of large-scale treatment roll-out. Methods and Findings We used an epidemiologic model of HIV/AIDS, calibrated to sub-Saharan Africa, to investigate a range of possible positive and negative health outcomes under alternative scenarios that reflect varying implementation of prevention and treatment. In baseline projections, reflecting "business as usual," the numbers of new infections and AIDS deaths are expected to continue rising. In two scenarios representing treatment-centered strategies, with different assumptions about the impact of treatment on transmissibility and behavior, the change in the total number of new infections through 2020 ranges from a 10% increase to a 6% reduction, while the number of AIDS deaths through 2020 declines by 9% to 13%. A prevention-centered strategy provides greater reductions in incidence (36%) and mortality reductions similar to those of the treatment-centered scenarios by 2020, but more modest mortality benefits over the next 5 to 10 years. If treatment enhances prevention in a combined response, the expected benefits are substantial--29 million averted infections (55%) and 10 million averted deaths (27%) through the year 2020. However, if a narrow focus on treatment scale-up leads to reduced effectiveness of prevention efforts, the benefits of a combined response are considerably smaller--9 million averted infections (17%) and 6 million averted deaths (16%). Combining treatment with effective prevention efforts could reduce the resource needs for treatment dramatically in the...


Related Articles

  • Game Changers in Global AIDS Fight. Minter, William // Foreign Policy in Focus;6/7/2011, p3 

    The author discusses the global fight against the AIDS epidemic in 2011. He believes that victories are seen ahead due to game-changing research, as well as documented successes in the past years. He cites developments in the global fight against AIDS including a scientific trial showing the...

  • HIV/AIDS-related Expectations and Risky Sexual Behaviour in Malawi. DELAVANDE, ADELINE; KOHLER, HANS-PETER // Review of Economic Studies;Jan2016, Vol. 83 Issue 1, p118 

    We use probabilistic expectations data elicited from survey respondents in rural Malawi to investigate how risky sexual behaviour may be influenced by individuals' expectations about survival, and future HIV-status, which in turn depend on the perceived impact of HIV/AIDS on survival,...

  • From the Editor. Myer, Landon // Southern African Journal of HIV Medicine;2014, Vol. 15 Issue 3, p75 

    An introduction is presented in which the editor discusses various reports within the issue on topics including the delivery of antiretroviral therapy across southern Africa, HIV infection management in children, and prevention of HIV transmission from mother to child.

  • Study shows anti-HIV drugs prevent sexual transmission.  // Africa Health;Jul2011, Vol. 33 Issue 5, p12 

    The article focuses on an international study that had been lauded by the United Nations agencies which shows that if an HIV-positive person follows an appropriate treatment of anti-retroviral drugs, the risk of transmitting the virus to an uninfected sexual partner is reduced.

  • Treatment reduces transmission by 96%.  // HIV Australia;2011, Vol. 9 Issue 2, p6 

    The article reports that according to the study HPTN 052, HIV positive people reduced risk of transmitting virus to their sexual partners by taking antiretrovirals.

  • Heterosexual PrEP trials success.  // HIV Australia;2011, Vol. 9 Issue 2, p6 

    The article reports that according to two studies Partners PrEP and CDC TDF2 conducted in Africa, taking antiretrovirals as preexposure prophylaxis (PrEP) reduces HIV transmission by up to 73 percent.

  • Are All HIV Type 1 Strains Created Equal? Campbell, Thomas B. // Clinical Infectious Diseases;3/15/2006, Vol. 42 Issue 6, p853 

    The article reflects on the author's views on HIV-1 infections. HIV-1 genetic diversity is very important for the design of vaccines to prevent HIV-1 infection. Cross-species transmission of chimpanzee simian immuno deficiency virus to humans has given rise to 3 distinct groups of HIV-1. The...

  • HIV Treatment Beliefs and Sexual Transmission Risk Behaviors among HIV Positive Men and Women. Kalichman, Seth C.; Eaton, Lisa; Cain, Demetria; Cherry, Charsey; Pope, Howard; Kalichman, Moira // Journal of Behavioral Medicine;Oct2006, Vol. 29 Issue 5, p401 

    People are living longer and healthier with HIV infection because of successful combination antiretroviral therapies. HIV treatment beliefs are often associated with sexual practices among people living with HIV/AIDS but these associations may depend on the HIV status of sex partners. In a...

  • Coping with HIV in Pakistan.  // Contemporary Sexuality;Oct2011, Vol. 45 Issue 10, p8 

    The article presents information on efforts to treat and prevent HIV and AIDS in Pakistan, noting how intravenous drug users and migrant workers returning from Arab states have increased concerns of HIV transmission.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics